Page last updated: 2024-09-03

dioscin and Inflammatory Response Syndrome, Systemic

dioscin has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, L; Liu, K; Peng, J; Sun, P; Xu, L; Xu, M; Yin, L; Zhao, X	1

Other Studies

1 other study(ies) available for dioscin and Inflammatory Response Syndrome, Systemic

Article	Year
Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF‑κb signal pathway. International immunopharmacology, 2018, Volume: 65 Topics: Animals; Anti-Inflammatory Agents; Dioscorea; Diosgenin; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Systemic Inflammatory Response Syndrome; THP-1 Cells; Toll-Like Receptor 2; Zymosan	2018

Article

Year

Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF‑κb signal pathway.

International immunopharmacology, 2018, Volume: 65

Topics: Animals; Anti-Inflammatory Agents; Dioscorea; Diosgenin; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Systemic Inflammatory Response Syndrome; THP-1 Cells; Toll-Like Receptor 2; Zymosan

2018